{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:32:05Z","timestamp":1789644725206,"version":"4.0.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.gyobfe.2011.02.010","type":"journal-article","created":{"date-parts":[[2012,2,23]],"date-time":"2012-02-23T01:05:55Z","timestamp":1329959155000},"page":"216-223","source":"Crossref","is-referenced-by-count":3,"title":["La canc\u00e9rogen\u00e8se ovarienne\u00a0: th\u00e9ories actuelles et pass\u00e9es"],"prefix":"10.1016","volume":"39","author":[{"given":"G.","family":"Ch\u00eane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Penault-Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Raoelfils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-J.","family":"Bignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Seffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dauplat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2011.02.010_bib0005","series-title":"Cancer de l\u2019ovaire","author":"Dauplat","year":"1996"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0010","first-page":"20","article-title":"Prevention of ovarian cancer: intra-epithelial neoplasia","volume":"9","author":"Brewer","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0001-4001(98)80014-7","article-title":"Prevention of ovarian cancer by prophylactic ovariectomy","volume":"123","author":"Dauplat","year":"1998","journal-title":"Chirurgie"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0020","unstructured":"Bignon YJ, Vaurs C, Vidal V. Pr\u00e9dispositions h\u00e9r\u00e9ditaires aux cancers des ovaries. In Cancer de l\u2019ovaire. Paris; Arnette Blackwell; 1996. p. 63\u20135"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(94)91578-4","article-title":"Risk of cancer in BRCA 1 mutation carriers","volume":"343","author":"Ford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0030","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0002-9343(86)90411-0","article-title":"Familial ovarian carcinoma","volume":"81","author":"Lynch","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","article-title":"Hereditary ovarian cancer: a clinicopathological study","volume":"11","author":"Bewtra","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0040","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA 2 genes in breast cancer families. The breast Cancer Linkage Consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","article-title":"The contribution of BRCA 1 and BRCA 2 to ovarian cancer","volume":"3","author":"Ramus","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0050","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/94.13.990","article-title":"Gene expression profiles of BRCA 1-linked, BRCA 2-linked, and sporadic ovarian cancers","volume":"94","author":"Jazaeri","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0055","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/0959-8049(94)00455-E","article-title":"BRCA 1, BRCA 2, BRCA 3: a myriad of breast cancer genes","volume":"30","author":"Bishop","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0060","first-page":"587","article-title":"Inherited predisposition to breast cancer: after the BRCA 1 and BRCA 2 genes, what next?","volume":"90","author":"Bonadona","year":"2003","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0065","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","article-title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","volume":"110","author":"Salvador","year":"2008","journal-title":"Gynecol oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0070","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.molonc.2009.01.001","article-title":"Molecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease","volume":"3","author":"Jazaeri","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molonc.2009.01.008","article-title":"Role of genetic polymorphisms and ovarian cancer susceptibility","volume":"3","author":"Fasdhing","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molonc.2009.02.004","article-title":"Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management","volume":"3","author":"Lynch","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0085","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/ng0495-439","article-title":"Somatic mutation in the BRCA 1 gene in sporadic ovarian tumours","volume":"9","author":"Merajver","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA 1 and BRCA 2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gyn Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/gyno.1999.5664","article-title":"Reduction of BRCA 1 expression in sporadic ovarian cancer","volume":"76","author":"Zheng","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/6029","article-title":"Localization of human BRCA 1 and its loss in high-grade, non-inherited breast carcinomas","volume":"21","author":"Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0105","first-page":"5329","article-title":"BRCA 1 promoter region hyper-methylation in ovarian carcinoma: a population-based study","volume":"60","author":"Baldwin","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","article-title":"Promoter hyper-methylation and BRCA 1 inactivation in sporadic breast and ovarian tumours","volume":"92","author":"Esteller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0115","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","article-title":"Inactivation of BRCA 1 and BRCA 2 in ovarian cancer","volume":"94","author":"Hilton","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0120","first-page":"3461","article-title":"Mice heterozygous for a BRCA 1 or BRCA 2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol","volume":"60","author":"Bennett","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0125","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.gyobfe.2008.05.003","article-title":"Ovarian epithelial dysplasia: myth or reality? Review","volume":"36","author":"Chene","year":"2008","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation: a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0135","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/j.0001-6349.2004.00550.x","article-title":"Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies","volume":"83","author":"Riman","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ijc.10927","article-title":"Ovulation and risk of epithelial ovarian cancer","volume":"104","author":"Purdie","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1289\/ehp.877335","article-title":"Ovarian tumours of the hen","volume":"73","author":"Fredrickson","year":"1987","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0150","unstructured":"Hamilton TC, Godwin AK, Ozols RF. Carcinogen\u00e8se ovarienne. In Cancer de l\u2019ovaire. Paris; Arnette Blackwell; 1996. p. 21\u201338."},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0155","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1471-0528.1982.tb05067.x","article-title":"Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report","volume":"89","author":"Bamford","year":"1982","journal-title":"Br J Obstet Gynaecol."},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0160","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/oxfordjournals.aje.a116427","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0165","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1056\/NEJM199409223311204","article-title":"Ovarian tumours in a cohort of infertile women","volume":"331","author":"Rossing","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0170","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2001.6227","article-title":"Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity","volume":"82","author":"Nieto","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0175","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/humrep\/den358","article-title":"Ovarian epithelial dysplasia after ovulation induction: time and dose effect","volume":"24","author":"Chene","year":"2009","journal-title":"Human Reprod"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0180","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1016\/j.ejca.2009.06.012","article-title":"Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer","volume":"45","author":"Dauplat","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.fertnstert.2005.08.061","article-title":"Induction of ovulation and ovarian cancer: a critical review of the literature","volume":"85","author":"Mahdavi","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1432-0436.1982.tb01229.x","article-title":"Evidence for follicle wall involvement in ovulation and progesterone production by grog follicles in vitro","volume":"22","author":"Schuetz","year":"1982","journal-title":"Differentiation"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0195","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-4320(97)00011-0","article-title":"Evidence for a role of the ovarian surface epithelium in the ovulatory mechanism of the sheep: secretion of urokinase-type plasminogen activator","volume":"47","author":"Colgin","year":"1997","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0739-7240(93)90019-8","article-title":"Factors contributing to the formation of experimentally induced ovarian cysts in prepubertal gilts","volume":"10","author":"Hall","year":"1993","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0205","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1095\/biolreprod33.3.729","article-title":"An autoradiographic study of rabbit ovarian surface epithelium before and after ovulation","volume":"33","author":"Osterholzer","year":"1985","journal-title":"Biol Reprod"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0210","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/rep.0.1230743","article-title":"Roles of the ovarian surface epithelium in ovulation and carcinogenesis","volume":"123","author":"Murdoch","year":"2002","journal-title":"Reproduction"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0215","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0378-4320(88)90022-X","article-title":"The plasminogen activator activity is marked increased mainly at the area of the rupture of the follicular wall at the time of ovulation","volume":"16","author":"Smokovitis","year":"1988","journal-title":"Anim Reprod Sci"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1432-1033.1993.tb17907.x","article-title":"Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator\u2013inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation","volume":"214","author":"Peng","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0225","unstructured":"Tsafriri A, Reich R. Plasminogen activators in the preovulatory follicle: role in ovulation. In plasminogen activators: from cloning to therapy; 1991. Ed. Abbate, Raven Press. p. 81\u201393"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0230","first-page":"569","article-title":"The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma","volume":"12","author":"Stack","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0235","first-page":"135","article-title":"Mettaloproteinases and urokinase in angiogenesis and tumor progression","volume":"12","author":"Rabbani","year":"1998","journal-title":"In Vivo"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0240","first-page":"3610","article-title":"Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B","volume":"52","author":"Kobayashi","year":"1992","journal-title":"Can Res"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0245","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/BF00133485","article-title":"Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice","volume":"13","author":"Wilhelm","year":"1995","journal-title":"Clin Exp metast"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0250","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1525-1438.2002.01152.x","article-title":"Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches","volume":"12","author":"Auersperg","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0255","first-page":"510","article-title":"Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes","volume":"71","author":"Auersperg","year":"1994","journal-title":"Lab Invest"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0260","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6","article-title":"Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer","volume":"69","author":"Dyck","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0265","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9440(10)65130-9","article-title":"Comparison of c-met expression in ovarian epithelial tumours and normal epithelia of the female reproductive tract by quantitative laser scan microscopy","volume":"155","author":"Huntsman","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0270","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1365-2559.2001.01042.x","article-title":"Precursor lesions of ovarian epithelial malignancy","volume":"38","author":"Feeley","year":"2001","journal-title":"Histopathology"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0275","first-page":"717","article-title":"Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0280","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6690731","article-title":"Hormone replacement therapy and risk of epithelial ovarian cancer","volume":"81","author":"Purdie","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0285","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/oxfordjournals.aje.a117055","article-title":"A case-control study of oral contraceptive use and invasive epithelial ovarian cancer","volume":"139","author":"Rosenberg","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0290","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone","volume":"90","author":"Rish","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(96)00216-8","article-title":"Estrogen action in human ovarian cancer","volume":"25","author":"Clinton","year":"1997","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0300","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0029-7844(98)00139-2","article-title":"Hormone replacement therapy and the risk of epithelial ovarian cancer: a meta-analysis","volume":"92","author":"Garg","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0305","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/(SICI)1097-0215(19970611)71:6<948::AID-IJC6>3.0.CO;2-Y","article-title":"Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer","volume":"71","author":"Green","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0310","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<351::AID-IJC7>3.0.CO;2-M","article-title":"Genital talc exposure and risk of ovarian cancer","volume":"81","author":"Cramer","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jnci\/92.2.162A","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"92","author":"Ness","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/gyno.1999.5649","article-title":"Infertility and ovarian cancer. Editorial","volume":"76","author":"Hardiman","year":"2000","journal-title":"Gyn Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0325","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0165-4608(96)00245-2","article-title":"High frequency of telomeric associations in human ovarian surface epithelial cells transformed by HPV oncogenes","volume":"95","author":"Wan","year":"1997","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0330","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000292496","article-title":"Detection of HPV RNA in ovarian and endometrial carcinomas by reverse transcription polymerase chain reaction","volume":"38","author":"Lai","year":"1994","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0335","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.onc.1200868","article-title":"20q gain associates with immortalisation; 20q 13.2 amplification correlates with genome instability in HPV 16 E7 transformed human uro-epithelial cells","volume":"14","author":"Savelieva","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0340","first-page":"201","article-title":"\u00c9tude histologique de la gonade \u00e0 differentiation ovarienne au cours de l\u2019organogen\u00e8se","volume":"37","author":"Hoang-Ngoc","year":"1989","journal-title":"Arch Anat Pathol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","article-title":"Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses","volume":"247","author":"Fleming","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0350","first-page":"181","article-title":"Morphologic precursors of ovarian epithelial tumours","volume":"82","author":"Resta","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0355","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cncr.2820710209","article-title":"Growth regulation and transformation of ovarian epithelium","volume":"71","author":"Berchuck","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0360","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) an dits prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0365","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0370","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0375","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA 1 and BRCA 2 carriers","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0380","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0385","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0390","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0395","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0400","first-page":"741","article-title":"Molecular abnormalities in epithelial ovarian tumours: present and future","volume":"88","author":"Vaurs-Barriere","year":"2001","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0405","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gyobfe.2011.02.010_bib0410","first-page":"151","article-title":"Pathogenesis of ovarian cancer. Lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.gyobfe.2011.02.010_bib0415","first-page":"1511","article-title":"Ovarian tumorigenesis. A proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Ming-Shih","year":"2004","journal-title":"Am J Pathol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique &amp; Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958911000488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958911000488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T04:08:18Z","timestamp":1561349298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958911000488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1297958911000488"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2011.02.010","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}